These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10096719)
1. The nature and extent of drug-related hospitalisations in Australia. Roughead EE J Qual Clin Pract; 1999 Mar; 19(1):19-22. PubMed ID: 10096719 [TBL] [Abstract][Full Text] [Related]
2. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543 [TBL] [Abstract][Full Text] [Related]
3. Trends in adverse drug reaction-related hospitalisations over 13 years in New South Wales, Australia. Zhang H; Du W; Gnjidic D; Chong S; Glasgow N Intern Med J; 2019 Jan; 49(1):84-93. PubMed ID: 30281186 [TBL] [Abstract][Full Text] [Related]
4. Adverse events in surgical patients in Australia. Kable AK; Gibberd RW; Spigelman AD Int J Qual Health Care; 2002 Aug; 14(4):269-76. PubMed ID: 12201185 [TBL] [Abstract][Full Text] [Related]
5. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Roughead EE; Gilbert AL; Primrose JG; Sansom LN Med J Aust; 1998 Apr; 168(8):405-8. PubMed ID: 9594953 [TBL] [Abstract][Full Text] [Related]
6. The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia. Roughead EE; Semple SJ; Rosenfeld E Int J Evid Based Healthc; 2016 Sep; 14(3):113-22. PubMed ID: 26886682 [TBL] [Abstract][Full Text] [Related]
7. The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021. Lim R; Ellett LMK; Semple S; Roughead EE Drug Saf; 2022 Mar; 45(3):249-257. PubMed ID: 35089582 [TBL] [Abstract][Full Text] [Related]
8. A comparison of iatrogenic injury studies in Australia and the USA. I: Context, methods, casemix, population, patient and hospital characteristics. Thomas EJ; Studdert DM; Runciman WB; Webb RK; Sexton EJ; Wilson RM; Gibberd RW; Harrison BT; Brennan TA Int J Qual Health Care; 2000 Oct; 12(5):371-8. PubMed ID: 11079216 [TBL] [Abstract][Full Text] [Related]
9. Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly. Price SD; Holman CD; Sanfilippo FM; Emery JD Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1159-70. PubMed ID: 23797984 [TBL] [Abstract][Full Text] [Related]
10. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005. Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876 [TBL] [Abstract][Full Text] [Related]
11. Adverse drug events and medication errors in Australia. Runciman WB; Roughead EE; Semple SJ; Adams RJ Int J Qual Health Care; 2003 Dec; 15 Suppl 1():i49-59. PubMed ID: 14660523 [TBL] [Abstract][Full Text] [Related]
12. Suboptimal medication-related quality of care preceding hospitalisation of older patients. Caughey GE; Kalisch Ellett LM; Goldstein S; Roughead EE Med J Aust; 2015 Sep; 203(5):220.e1-7. PubMed ID: 26852053 [TBL] [Abstract][Full Text] [Related]
13. Relationship between primary care visits and hospital admissions in remote Indigenous patients with diabetes: a multivariate spline regression model. Zhao Y; Connors C; Lee AH; Liang W Diabetes Res Clin Pract; 2015 Apr; 108(1):106-12. PubMed ID: 25666107 [TBL] [Abstract][Full Text] [Related]
15. A comparison of iatrogenic injury studies in Australia and the USA. II: Reviewer behaviour and quality of care. Runciman WB; Webb RK; Helps SC; Thomas EJ; Sexton EJ; Studdert DM; Brennan TA Int J Qual Health Care; 2000 Oct; 12(5):379-88. PubMed ID: 11079217 [TBL] [Abstract][Full Text] [Related]
16. The incidence of public sector hospitalisations due to dog bites in Australia 2001-2013. Rajshekar M; Blizzard L; Julian R; Williams AM; Tennant M; Forrest A; Walsh LJ; Wilson G Aust N Z J Public Health; 2017 Aug; 41(4):377-380. PubMed ID: 28712151 [TBL] [Abstract][Full Text] [Related]
17. Adverse drug reaction-related hospitalisations: a population-based cohort study. van der Hooft CS; Dieleman JP; Siemes C; Aarnoudse AJ; Verhamme KM; Stricker BH; Sturkenboom MC Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):365-71. PubMed ID: 18302300 [TBL] [Abstract][Full Text] [Related]
18. Australian hospitalisations for Kawasaki disease, 1993-1994 to 2017-2018. O'Brien K J Paediatr Child Health; 2020 Jul; 56(7):1126-1133. PubMed ID: 32162771 [TBL] [Abstract][Full Text] [Related]
19. Incidence, costs, and temporal trends of sports injury-related hospitalisations in Australian children over a 10-year period: A nationwide population-based cohort study. Lystad RP; Curtis K; Browne GJ; Mitchell RJ J Sci Med Sport; 2019 Feb; 22(2):175-180. PubMed ID: 30314855 [TBL] [Abstract][Full Text] [Related]
20. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Dartnell JG; Anderson RP; Chohan V; Galbraith KJ; Lyon ME; Nestor PJ; Moulds RF Med J Aust; 1996 Jun; 164(11):659-62. PubMed ID: 8657028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]